Finally, earlier studies have connected PKD1 mutations and CRC risk [8], and also suggested that elevated levels of PKD1 in late-stage tumors and tumor-derived cell lines are associated with more invasive phenotypes due to increased EMT and migration, and worse survival [16]. This evidence concerns the gene PKD1 and neoplasm.